首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Achieving glycaemic control without weight gain hypoglycaemia or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

【2h】

Achieving glycaemic control without weight gain hypoglycaemia or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

机译：在SUSTAIN临床试验计划中实现血糖控制而无体重增加低血糖或胃肠道不良事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

AimTo evaluate the potential for semaglutide to help people with type 2 diabetes (T2D) achieve glycated haemoglobin (HbA1c) targets while avoiding unwanted outcomes, such as weight gain, hypoglycaemia and gastrointestinal (GI) side effects.

机译：目的评估塞玛鲁肽在帮助2型糖尿病（T2D）患者达到糖化血红蛋白（HbA1c）目标，同时避免不良后果（例如体重增加，低血糖和胃肠道（GI）副作用）方面的潜力。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
J. Hans DeVries; Cyrus Desouza; Srikanth Bellary; Jeffrey Unger; Oluf K. H. Hansen; Jeppe Zacho; Vincent Woo;
展开▼
作者单位

展开▼
年(卷),期 -1(20),10
年度 -1
页码 2426–2434
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
GLP‐1 glycaemic control hypoglycaemia type 2 diabetes;

机译：GLP-1;血糖控制;低血糖;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme [J] . DeVries J. Hans, Desouza Cyrus, Bellary Srikanth, Diabetes, obesity & metabolism . 2018,第10期

机译：在维持临床试验计划中实现2型糖尿病中没有体重增加，低血糖或胃肠不良事件的血糖控制
2. Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme. [J] . Zinman B, Schmidt WE, Moses A, Diabetes, obesity & metabolism . 2012,第1期

机译：在2型糖尿病中实现HbA1c <7％且无体重增加或低血糖的临床相关综合结果：利拉鲁肽临床试验计划的荟萃分析。
3. Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study [J] . Bajaj M., Gilman R., Patel S., Diabetic medicine: A journal of the British Diabetic Association . 2014,第12期

机译：对二甲双胍和吡格列酮联合治疗不能充分控制的2型糖尿病患者，利格列汀可改善血糖控制而无体重增加或低血糖：一项为期24周的随机双盲研究
4. Prescription of energy-restricted diets with higher and lower pork protein content achieves weight loss and improved glycaemic control in adults with type 2 diabetes [C] . N. A. Watson, K. A. Dyer, J. D. Buckley, Biennial Conference of the Australasian Pig Science Association . 2015

机译：具有较高和较低猪肉蛋白质含量的能量限制饮食处方实现了2型糖尿病的成人体重减轻和改善血糖控制
5. Feasibility Study of a Randomized Controlled Trial Protocol to Examine the Effectiveness of Auriculotherapy (AT) in Improving Sleep Condition and Glycaemic Control in Clients with Type 2 Diabetes. [D] . Kwan, Yee Mei. 2013

机译：一项随机对照试验方案的可行性研究，以检查耳穴疗法（AT）改善2型糖尿病患者睡眠状况和血糖控制的有效性。
6. Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized double-blind study [O] . M Bajaj, R Gilman, S Patel, -1

机译：利格列汀改善了二甲双胍和吡格列酮联用不能充分控制的2型糖尿病患者的血糖控制而无体重增加或低血糖：一项为期24周的随机双盲研究
7. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study [O] . L. F. Meneghini, K. H. Rosenberg, C. Koenen, 2007

机译：胰岛素Deedemir改善血糖控制较少的低血糖和2型糖尿病患者没有体重增加，患有胰岛素幼稚或用NPH或胰岛素狼犬治疗：从预测研究的德国亚组的临床实践经验

Achieving glycaemic control without weight gain hypoglycaemia or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅